Levodopa-impurities | Pharmaffiliates

levodopa

Also known as L-Dopa which is an amino acid that acts as a precursor for neurotransmitters catecholamines (dopamine, norepinephrine, and epinephrine). Levodopa is used in the treatment of Parkinson's disease and dopamine-responsive dystonia. Reference standards of Levodopa API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Levodopa (IPRS/131/12)-from IPC
    [catalogue_number] => PA IPIPRS 131 12
    [category_ids] => ,151,
    [chemical_name] => 
    [weight] => NA
    [form] => 
    [cas] => NA
    [pslug] => levodopa-iprs-131-12-paipiprs13112
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA IPIPRS 131 12

Levodopa (IPRS/131/12)-from IPC


  • Catalogue No.:PA IPIPRS 131 12

  • CAS :

    NA

  • Molecular Formula :

  • Molecular Weight : NA

stdClass Object
(
    [pname] => Levodopa (IPRS/06/19)
    [catalogue_number] => PA IPRS 06 19
    [category_ids] => ,151,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => levodopa-iprs-06-19-paiprs0619
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA IPRS 06 19

Levodopa (IPRS/06/19)


  • Catalogue No.:PA IPRS 06 19

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA